Drug could save around 600 lives per year.

NHS to allow free access to Taxotere, a drug for early breast cancer treatment.

On 27 September 2006 National Institute for Health and Clinical Excellence (NICE), which decides which treatments are to be made available on the NHS, announced that women diagnosed with early breast cancer will have the the option to benefit from free access to Taxotere (docetaxel), a potentially life-saving treatment.

"The approval of TAC for adjuvant treatment of women with early Breast Cancer is a genuine breakthrough," says Dr Paul Ellis, Consultant Medical Oncologist, Guys & St Thomas, London. "To put this in context this is the latest in a series of developments in improving adjuvant chemotherapy for women with this disease. The addition of Taxotere shows evidence for further survival benefit and builds on the advances seen with CMF in the 70's and 80's and anthracyclines in the 90's."


This content was created on Mon 2 October 2006

More like this
Women's Health
Illnesses
Treatments
News and Comment
Use this page



Privacy Terms | Advertisers | Legal Disclaimer | Contact
© 2007 TheFamilyGP.com